Is zoloft activating or sedating
AD's more stimulating than Bupropion include: Reboxetine, Protriptyline and possibly Desipramine.There will always be those opposed to any psychoactive medication for children and there will always be those who see a pill as a solution for everything.Attention-deficit Hyperactivity Disorder (ADHD) is not a new diagnosis.It was referred to as hyperkinesis, minimal brain damage, and Attention-deficit Disorder (ADD) with and without hyperactivity in the past.She is best known for her research and teaching on mood disorders, especially BD and its comorbidities, in young people. (2003), Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children attention deficit hyperactivity disorder titration trial. Geller B, Fox LW, Fletcher M (1993), Effect of tricyclic antidepressants on switching to mania and on the onset of bipolarity in depressed 6- to 12-year-olds. Aman MG (2004), Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder. Aman MG, Buican B, Arnold LE (2003), Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies. Beasley CM Jr, Potvin JH (1993), Fluoxetine: activating and sedating effects. Beasley CM Jr, Sayler ME, Bosomworth JC, Wernicke JF (1991), High-dose fluoxetine: efficacy and activating-sedating effects in agitated and retarded depression. (2003), Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Cherland E, Fitzpatrick R (1999), Psychotic side effects of psychostimulants: a 5-year review. Connor DF (2002), Preschool attention deficit hyperactivity disorder: a review of prevalence, diagnosis, neurobiology, and stimulant treatment. Curran C, Byrappa N, Mc Bride A (2004), Stimulant psychosis: systematic review. everyone is different, but from my own expierence...Prozac-Zoloft-Lexapro-Paxilpaxil being the most sedating.never tried Luvox before.
Why do you want to try another SSRI, but not another antidepressant?Behavioral toxicity to different drugs may look similar but does not necessarily reflect the same mechanisms. (2001), Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. For instance, no one describes acute alcohol-induced disinhibition (intoxication) or benzodiazepine/barbiturate-induced paradoxical reactions in children as examples of secondary mania, yet behaviorally they are quite similar. Carlson is professor and director of child and adolescent psychiatry at Stony Brook University School of Medicine. (2001), Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder. Ghaemi SN, Hsu DJ, Soldani F, Goodwin FK (2003), Antidepressants in bipolar disorder: the case for caution. Typically at lower doses Venlafaxine is quite sedating while above 200mg it becomes quite activating.Duloxetine for example is a slightly stronger NRI than Venlafaxine and so tends to be more activating. So other than placing Bupropion at the top you can't really decide one is more stimulating than another.There is no way to answer that question - people respond very differently.With Tranylcypromine for example a lot of people find it quite sedating.Although there is some overlap, terms used to describe selective serotonin reuptake inhibitor-related activation events are not synonymous and include irritability, anger outbursts, excitability, manic symptoms, hyperkinesis, hyperactivity, agitation, nervousness, lability, hostility and motor activity.Second, in the published literature, anecdotal reports far outnumber systematic studies.Also, we are just beginning to learn about factors related to individual differences in drug metabolism. (2001), Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. (2004), Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. Arch Pediatr Adolesc Med 158(8):773-780 [see comment]. (2001), Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Nolan EE, Gadow KD, Sprafkin J (1999), Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder. Pine DS, Klein RG, Lindy DC, Marshall RD (1993), Attention-deficit hyperactivity disorder and comorbid psychosis: a review and two clinical presentations. Developmental factors are crucial and include immaturity of neuroendocrine systems, changes in blood-brain barriers, levels of detoxifying enzymes and ongoing development of neural circuitry (Vitiello and Jensen, 1995). (2004), Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Handen BL, Johnson CR, Lubetsky M (2000), Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder. Hazell P, O'Connell D, Heathcote D, Henry D (2002), Tricyclic drugs for depression in children and adolescents. J Am Acad Child Adolesc Psychiatry 40(7):762-772 [see comments]. (2003), Defining clinical phenotypes of juvenile mania.